Chemours (CC)
(Delayed Data from NYSE)
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Zacks News
CC or PPG: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CC vs. PPG: Which Stock Is the Better Value Option?
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.
Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?
by Zacks Equity Research
Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.
Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JPME
Should Value Investors Buy Chemours (CC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CC vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
CC vs. ALB: Which Stock Is the Better Value Option?
Are Basic Materials Stocks Lagging Chemours (CC) This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Silica Holdings (SLCA) have performed compared to their sector so far this year.
Chemours (CC) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
Higher prices contribute favorably to Chemours' (CC) top-line growth in the second quarter.
Chemours (CC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 33.10% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Chemours' (CC) second-quarter performance is likely to reflect the increasing adoption of Opteon refrigerants and the benefits of cost-cutting measures.
Earnings Preview: LyondellBasell (LYB) Q2 Earnings Expected to Decline
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Chemours (CC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Best Growth Stocks to Buy for June 29th
by Zacks Equity Research
CIB, CC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2022.
New Strong Buy Stocks for June 27th
by Zacks Equity Research
BSAC, CPLP, CC, OTTR, and DELL have been added to the Zacks Rank #1 (Strong Buy) List on June 27, 2022.
Best Value Stocks to Buy for June 27th
by Zacks Equity Research
CPLP, CC, and DELL made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 27, 2022.
Best Income Stocks to Buy for June 27th
by Zacks Equity Research
BSAC, CPLP, and CC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 27, 2022.
Chemours (CC) Stock Jumps 7.4%: Will It Continue to Soar?
by Zacks Equity Research
Chemours (CC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CC vs. FMC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CC vs. FMC: Which Stock Is the Better Value Option?
Are Investors Undervaluing Chemours (CC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Momentum Stocks to Buy for June 22nd
by Zacks Equity Research
CC, KR, and OSBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 22, 2022.
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $31.44, moving -0.47% from the previous trading session.
Nutrien (NTR) to Increase Fertilizer Production & Return Capital
by Zacks Equity Research
Nutrien (NTR) intends to boost annual potash manufacturing capacity to 18 million tons by 2025 due to the supply uncertainty from Eastern Europe.
U.S. Silica (SLCA) Completes Review of ISP Unit Alternatives
by Zacks Equity Research
U.S. Silica's (SLCA) Board determines that retaining ownership of the ISP segment would be the best path forward.
Univar (UNVR) Expands Collaboration With BASF, Boosts Portfolio
by Zacks Equity Research
Univar (UNVR) expands its partnership with BASF to better serve customers through a range of sustainable solutions across various applications.
Is Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Cabot (CBT) have performed compared to their sector so far this year.